Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2013; 19(33): 5485-5492
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5485
Figure 5
Figure 5 Propofol inhibits constitutively active nuclear factor-κB in MIA-PaCa-2 cells. A: MIA-PaCa-2 cells were treated with 0, 10, 25, 50, or 100 μmol/mL propofol for 72 h and nuclear extracts were probed for nuclear factor-κB (NF-κB) binding to a DNA consensus sequence. Results of NF-κB DNA-binding activity by electrophoretic mobility shift assay (EMSA); B: MIA-PaCa-2 cells were treated with 100 μmol/mL propofol for 24, 48, or 72 h and nuclear extracts were probed for NF-κB binding to a DNA consensus sequence. Results of NF-κB DNA-binding activity by EMSA. Retinoblastoma protein in the nuclear extract was used as a loading control.